Two new vaccines, both developed in Cuba, have shown remarkable efficacy in clinical trials. It is crucial to remember that Cuba developed these vaccines even as it continues to suffer under the crippling blockade imposed by the US.

The Abdala vaccine showed 92.28% efficacy with three doses during the third phase of clinical trials and the Soberana 02 vaccine showed 62% efficacy with just two of its three doses

With its development of five COVID-19 vaccines and the promise of sharing know-how with developing countries, Cuba has remained faithful to Che Guevara’s values of international solidarity and people-oriented medicine